Loading stock data...
Rigel Pharmaceuticals, Inc. (RIGL) Stock Price, Chart & Analysis
Rigel Pharmaceuticals, Inc.RIGL
Market Closed$40.07
+$0.56+1.42%
RIGL Market Indicators
Very Bullish
Market Sentiment
Historical Price Chart
View the historical price chart for RIGL to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Rigel Pharmaceuticals, Inc. (RIGL)
Loading chart data...
Is Rigel Pharmaceuticals, Inc. (RIGL) Stock a Buy in 2025?
YES
STRONG BUY
Score: 95/100
Yes, RIGL stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether RIGL stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 53.4%
- Strong profit margins of 36.5%
- Healthcare sector momentum
Valuation Considerations
- Small-cap with higher growth potential and volatility
Risk Factors
- High debt-to-equity ratio of 74.50
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:6
Hold Ratings:3
Sell Ratings:1
Avg. Price Target:$38.33
Upside Potential:-4.3%
Investment Summary
RIGL presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 53.4%, though small-cap with higher growth potential and volatility.
Analyst sentiment is generally positive with 6 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 74.50, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:95/100
Strong Buy
2030 Price Prediction
Predicted Price:$122.28
Potential Return:+205.2%
Key Factors
- Exceptional revenue growth
- Strong analyst buy consensus
- Exceptional long-term growth potential to 2030
- Wide analyst target range indicates uncertainty
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 8.5% (Very Low)
Investment Decision
Based on our comprehensive analysis of RIGL's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
rigl Stock Price Prediction 2030
Predicted 2030 Price
$122.28
+205.2%from current price
Based on revenue growth analysis and market trends, rigl stock is projected to reach $122.28 by 2030, representing a 205.2% increase from the current price of $40.07.
Current Price
$40.07
Revenue Growth
176.0%
Analyst Target
$38.33
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in rigl Stock?
Quick Investment Insights for rigl
Attractive P/E: 7.38High Volatility (Beta: 1.21)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Rigel Pharmaceuticals, Inc.
Healthcare
Biotechnology
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company'...
Employees
162
Market Cap
$718.75M